Treatment of Schizoaffective Disorder Using Mifepristone
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Psychotic Disorders, Depressive Disorder, Major, Depressive Disorder
In brief
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Key facts
- Study ID
- NCT00725270
- Run by
- Stanford University
- People needed
- 12
- Starts
- 1998-04-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2017-03-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.